Suprane Liquid
Product Images NDC 10019-641

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Suprane (NDC 10019-641). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Suprane Chemical Structure Image (Image 01)

FDA Label Image

Figure 1. Paco2 During Spontaneous Ventilation In Unstimulated Volunteers (Image 02)

FDA Label Image

Figure 2. Desflurane Washin (Image 03)

FDA Label Image

Figure 3. Desflurane Washout (Image 04)

FDA Label Image

Suprane Representative Container Label (Image 05)

Suprane Representative Container Label (Image 05)
This is a description of a medication labeled as NDC 10019-641-60, named Suprane, which is a liquid for inhalation. The volume of the liquid is 240mL and it is meant to be administered by a doctor only. It appears to be an anesthetic drug, but no further details are provided.*
FDA Label Image

Suprane Representative Shipper/carton Label (Image 06)

Suprane Representative Shipper/carton Label (Image 06)
This is a product description for Suprane 10019-641-34, which is desflurane, a medication used for anesthesia. The package contains 6 bottles, each with a volume of 240 mL. It is recommended to store the product at room temperature between 15°C-30°C (59°F-86°F). The expiration date is indicated as 99 8888 Lot. The text includes a manufacturer's information: Mfd. for Baxter Healthcare Corporation, Deerfield, IL 60015 USA. The last line appears to be a code or identifier and does not provide further information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.